Banaschewski, T, Buitelaar, J, Chui, CS, Coghill, D, Cortese, S, Simonoff, E, Wong, IC (2016). Methylphenidate for ADHD in children and adolescents: throwing the baby out with the bathwater. Evidence-Based Mental Health 19, 97–99.
Castells, X, Ramos-Quiroga, JA, Rigau, D, Bosch, R, Nogueira, M, Vidal, X, Casas, M (2011). Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis. CNS Drugs 25, 157–169.
Catalá-López, F, Hutton, B, Núñez-Beltrán, A, Page, MJ, Ridao, M, Macías Saint-Gerons, D, Catalá, MA, Tabarés-Seisdedos, R, Moher, D (2017). The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: a systematic review with network meta-analyses of randomised trials. PLoS One 12, e0180355.
Cooper, WO, Habel, LA, Sox, CM, Chan, KA, Arbogast, PG, Cheetham, TC, Murray, KT, Quinn, VP, Stein, CM, Callahan, ST, Fireman, BH, Fish, FA, Kirshner, HS, O‘Duffy, A, Connell, FA, Ray, WA (2011). ADHD drugs and serious cardiovascular events in children and young adults. New England Journal of Medicine 365, 1896–1904.
Cortese, S, Adamo, N, Mohr-Jensen, C, Hayes, AJ, Bhatti, S, Carucci, S, Del, GC, Atkinson, LZ, Banaschewski, T, Simonoff, E, Zuddas, A, Barbui, C, Purgato, M, Steinhausen, H-C, Shokraneh, F, Xia, J, Cipriani, A, Coghill, D; European ADHD Guidelines Group (EAGG) (2017). Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis. BMJ Open 7, e013967.
Cortese, S, Ferrin, M, Brandeis, D, Buitelaar, J, Daley, D, Dittmann, RW, Holtmann, M, Santosh, P, Stevenson, J, Stringaris, A, Zuddas, A, Sonuga-Barke, EJ; European ADHD Guidelines Group (EAGG) (2015). Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials. Journal of American Academy of Child Adolescent Psychiatry 54, 164–174.
Cortese, S, Ferrin, M, Brandeis, D, Holtmann, M, Aggensteiner, P, Daley, D, Santosh, P, Simonoff, E, Stevenson, J, Stringaris, A, Sonuga-Barke, EJ; European ADHD Guidelines Group (EAGG) (2016). Neurofeedback for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials. Journal of American Academy of Child and Adolescent Psychiatry 55, 444–455.
Cortese, S, Holtmann, M, Banaschewski, T, Buitelaar, J, Coghill, D, Danckaerts, M, Dittmann, RW, Graham, J, Taylor, E, Sergeant, J; European ADHD Guidelines Group (2013). Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. Journal of Child Psychology and Psychiatry 54, 227–246.
Cortese, S, Rosello-Miranda, R (2017). [Treatments for children and adolescents with attention deficit hyperactivity disorder: what is the evidence base to date?]. Nature Reviews Neurology 64, S3–S7.
Habel, LA, Cooper, WO, Sox, CM, Chan, KA, Fireman, BH, Arbogast, PG, Cheetham, TC, Quinn, VP, Dublin, S, Boudreau, DM, Andrade, SE, Pawloski, PA, Raebel, MA, Smith, DH, Achacoso, N, Uratsu, C, Go, AS, Sidney, S, Nguyen-Huynh, MN, Ray, WA, Selby, JV (2011). ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA 306, 2673–2683.
Hoekstra, PJ, Buitelaar, JK (2016). Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed? European Child and Adolescent Psychiatry 25, 339–340.
Koesters, M, Becker, T, Kilian, R, Fegert, JM, Weinmann, S (2009). Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder. Journal of Psychopharmacology 23, 733–744.
Leucht, S, Hierl, S, Kissling, W, Dold, M, Davis, JM (2012). Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses. British Journal of Psychiatry 200, 97–106.
Lichtenstein, P, Halldner, L, Zetterqvist, J, Sjolander, A, Serlachius, E, Fazel, S, Långström, N, Larsson, H (2012). Medication for attention deficit-hyperactivity disorder and criminality. New England Journal of Medicine 367, 2006–2014.
Maia, CR, Cortese, S, Caye, A, Deakin, TK, Polanczyk, GV, Polanczyk, CA, Rohde, LA (2014). Long-term efficacy of methylphenidate immediate-release for the treatment of childhood ADHD: a systematic review and meta-analysis. Journal of Attention Disorder 21, 3–13.
Romanos, M, Coghill, D, Gerlach, M, Becker, K, Holtmann, M, Dopfner, M, Banaschewski, T (2016). Check and double check – the Cochrane review by Storebo et al. (2015) is indeed flawed. Zeitschrift Fur Kinder Und Jugendpsychiatrie Und Psychotherapie 44, 336–337.
Rubia, K, Alegria, AA, Cubillo, AI, Smith, AB, Brammer, MJ, Radua, J (2014). Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Biological Psychiatry 76, 616–628.
Schachter, HM, Pham, B, King, J, Langford, S, Moher, D (2001). How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ 165, 1475–1488.
Schelleman, H, Bilker, WB, Strom, BL, Kimmel, SE, Newcomb, C, Guevara, JP, Daniel, GW, Cziraky, MJ, Hennessy, S (2011). Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics 127, 1102–1110.
Shin, JY, Roughead, EE, Park, BJ, Pratt, NL (2016). Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study. BMJ 353, i2550.
Sonuga-Barke, EJ, Brandeis, D, Cortese, S, Daley, D, Ferrin, M, Holtmann, M, Stevenson, J, Danckaerts, M, van der Oord, S, Döpfner, M, Dittmann, RW, Simonoff, E, Zuddas, A, Banaschewski, T, Buitelaar, J, Coghill, D, Hollis, C, Konofal, E, Lecendreux, M, Wong, IC, Sergeant, J; European ADHD Guidelines Group (2013). Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. American Journal of Psychiatry 170, 275–289.
Stevenson, J, Buitelaar, J, Cortese, S, Ferrin, M, Konofal, E, Lecendreux, M, Simonoff, E, Wong, IC, Sonuga-Barke, E (2014). Research Review: The role of diet in the treatment of attention-deficit/hyperactivity disorder – an appraisal of the evidence on efficacy and recommendations on the design of future studies. Journal of Child Psychology and Psychiatry 55, 416–427.
Storebo, OJ, Ramstad, E, Krogh, HB, Nilausen, TD, Skoog, M, Holmskov, M, Rosendal, S, Groth, C, Magnusson, FL, Moreira-Maia, CR, Gillies, D, Buch Rasmussen, K, Gauci, D, Zwi, M, Kirubakaran, R, Forsbøl, B, Simonsen, E, Gluud, C (2015). Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database of Systematic Review 11, CD009885.
Van der Oord, S, Prins, PJ, Oosterlaan, J, Emmelkamp, PM (2008). Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis. Clinical Psychology Review 28, 783–800.